South Africa: Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs

Business Day (Johannesburg)

1 July 2008

SA's biggest generic drug manufacturer, Aspen Pharmacare Holdings, said yesterday it has bought four of GlaxoSmithKline's older, offpatent drugs for R2,7bn.

[ See Article ]

Read Our Commenting Guidelines

AllAfrica - All the Time

Most Active Stories

Uganda: Will Criminalising HIV Spread Help in Fight Against Virus?
Guinea: Ecowas Calls on Junta to Step Down
Nigeria: Yar'Adua's Health Worsens
Sudan: Govt Arrests Leading Southern Politicians
Ethiopia: Cool Breeze Over Addis
Zimbabwe: Threat to Dump Mugabe at Ruling Party Congress
Africa: Aids - No We Can't?
Nigeria: Obasanjo Lobbies for New Vice President
Guinea: Interim Leader Places Bounty On Assassin's Head
Nigeria: As Camara, Junta Lead Guinea Towards Anarchy
More Most Active >>

South Africa: Aspen Pays R2,7 Billion for Offpatent Glaxo Drugs

Most Active Stories

Topics